Objectives: To describe the phenotype of Leber congenital amaurosis (LCA) in 26 probands with mutations in aryl hydrocarbon receptor interacting proteinlike 1 protein (AIPL1) and compare it with phenotypes of other LCA-related genes. To describe the electroretinogram (ERG) in heterozygote carriers.
tion, were noted. Atrophic and/or pigmentary macular changes were present in 16 (80%) of 20 probands. Keratoconus and cataracts were identified in 5 (26%) of 19 patients, all of whom were homozygotes. The ERG of a parent heterozygote carrier revealed significantly reduced rod function, while ERGs for 6 other carrier parents were normal.
Conclusions:
The phenotype of LCA in patients with AIPL1 mutations is relatively severe, with a maculopathy in most patients and keratoconus and cataract in a large subset. Rod ERG abnormalities may be present in heterozygous carriers of AIPL1 mutations.
Clinical Relevance: Understanding and recognizing the phenotype of LCA may help in defining the course and severity of the disease. Identifying the gene defect is the first step in preparation for therapy since molecular diagnosis in LCA will mandate the choice of treatment.
Arch Ophthalmol. 2004; 122:1029 -1037 L EBER CONGENITAL AMAUROsis (LCA) was first described by Theodore Leber in 1869 1 as a congenital form of retinitis pigmentosa. It represents a clinically and genetically heterogeneous disorder with severe visual impairment from birth. 2, 3 Fundus examination results are not frequently initially normal, but chorioretinal atrophy, narrowing of the retinal vasculature, intraretinal pigment migration, white fundus flecks, and macular aplasia have been described. [4] [5] [6] [7] [8] The retinal basis of the visual loss is shown by absent or severely diminished rod and cone responses on electroretinography (ERG). 9 Nystagmus, enophthalmos, sluggish pupillary responses, keratoconus, cataracts, and hyperopia have also been described. [10] [11] [12] Leber congenital amaurosis is usually inherited as an autosomal recessive trait, although dominant inheritance has been reported. [13] [14] [15] [16] Currently, mutations in 6 different retinal genes have been shown to cause LCA. The genes include (1) retinal guanylate cyclase (GUCY2D), 17 (2) retinal pigment epithelium-specific 65kD protein (RPE65), 18 (3) cone-rod homeobox (CRX), [19] [20] [21] [22] (4) crumbs gene homolog of CRB1, 23, 24 (5) retinitis pigmentosa GTPase regulator-interacting protein (RPGRIP-1), 25, 26 and (6) AIPL1, encoding the aryl hydrocarbon receptor interacting protein-like 1 protein. 27, 28 The AIPL1 gene consists of 6 exons and encodes a protein of 384 amino acids. This sequence includes 3 tetratricopeptide repeat motifs thought to be associated with protein-protein interaction, and its similarity with aryl hydrocarbon interacting protein is suggestive of a protein folding function. 27, 28 The exact functions of the AIPL1 gene are not fully understood. However, recent data suggest that the protein may be involved in photoreceptor differ-
OPHTHALMIC MOLECULAR GENETICS
Author affiliations are listed at the end of the article. entiation during development and subsequent survival of photoreceptors. 29 Indeed, through interaction with the NUB1 protein, it might be involved in regulation of the cell-cycle progression during photoreceptor maturation. 29 Mutations in AIPL1 account for 7% of LCA. 28 Clinical outcomes differed for patients with LCA and GUCY2D mutations when compared with those with RPE65 defects [30] [31] [32] [33] in terms of the natural history of this disorder. In addition, some heterozygous carriers of GUCY2D mutations, who have offspring with LCA, have been shown to have significant cone abnormalities on ERG results, with essentially normal rod ERG findings. 34 Most heterozygotes with RPE65 mutations have normal ERG findings. 32 The purpose of this large study is to describe the phenotype of LCA in patients with AIPL1 mutations and compare it with the known phenotypes of patients with mutations in other LCA genes. The phenotype of 26 patients with LCA of different ethnic origins with mutations in AIPL1 is described. The genotype of most patients has previously been published. 15, 28 The ERG and clinical findings in a female heterozygous carrier are also reported.
METHODS
Informed consent was obtained from all patients involved in this study or from their legal guardians in accordance with the Declaration of Helsinki. The review and ethics boards of the institutions approved this study.
OPHTHALMIC EVALUATIONS
The clinical diagnosis of LCA was made on the basis of the following diagnostic criteria: severe visual impairment from birth or during early infancy accompanied by nystagmus, absent or very sluggish pupillary responses, and absent or markedly reduced rod and cone ERGs. All ERGs were performed according to the International Society for Clinical Electrophysiology of Vision standards. 35 The examinations were undertaken in 5 centers and included slitlamp biomicroscopy, retinoscopy, and indirect ophthalmoscopy following pupillary dilation ( Table 1) . Clinical pictures were taken, and keratometry was performed.
GENETIC EVALUATIONS
DNA was extracted from peripheral blood leukocytes or cheek swabs. A cohort of 303 patients with LCA was screened for mutations in AIPL1. Patients were from a wide range of racial and ethnic backgrounds. The 6 exons of AIPL1 were screened using single-strand conformation polymorphism analysis (SSCP) followed by direct sequencing when an aberrant migration pattern was noted on the SSCP gels. In 39 probands, direct sequencing was used to screen for mutations in AIPL1, while in the others, SSCP was initially undertaken using primers and conditions previously described. 27 The genotype of most of the patients with AIPL1-related LCA in this study has been published previously (Figure 1) . 27, 28 
RESULTS
Mutations in AIPL1 were detected in 26 probands with LCA ( Figure 1 ). Seventeen probands were homozygotes, while 9 were compound heterozygotes. Twentyfour of the 52 mutated AIPL1 alleles carried the W278X mutation. All sequence changes identified in our patients were absent in 205 control samples.
NIGHT BLINDNESS, PHOTOATTRACTION, AND PHOTOAVERSION
Night blindness was reported in 13 probands and photoaversion in 4. Photoattraction (staring at lights) was noted in 2 probands (Table 1) .
VISUAL ACUITIES AND CYCLOPLEGIC REFRACTIONS
Visual acuities were found to vary between probands and ranged from 20/400 to light perception. Nine patients had light perception. Seven patients had hand motion vision (Table 1) . Cycloplegic refractions performed in 10 patients showed hyperopia in 8 (+3.00 diopters [D] to +7.00 D) and myopia in 2 (-0.50 D to -2.75 D).
RETINAL AND MACULAR APPEARANCE
Twenty-four probands with an AIPL1-related LCA genotype had some form of pigmentary retinopathy that ranged from mild midperipheral salt and pepper-like retinopathy to diffuse and severe chorioretinopathy (Figures 2,  3 , 4, 5, 6 and 7). The youngest patient with pigmentary changes was 4 months old. Two patients, a 2-yearold and a 3-year-old, had essentially normal retinas with indistinct foveal reflexes. A maculopathy of variable appearance was noted in a significant number of patients (Figures 2, 3 , 4, 5, and 7). Information about the macular appearance was available in 20 of the 26 probands. Maculopathy was noted in 16 (80%) of 20 probands. In 4 probands, all young children (ranging from ages 2-6 years), an abnormal indistinct foveal reflex was noted, which likely represents an early stage of maculopathy. This strongly suggests that a significant number of patients with LCA and AIPL1 mutations develop a maculopathy. The maculopathy ranged in appearance from mild foveal atrophy with variable degrees of macular stippling to aplasia. The youngest patient with macular atrophy was 8 years old (Table 1) .
KERATOCONUS AND CATARACTS
Information about the presence of keratoconus was available in 19 probands (Table 1) . Keratoconus was diagnosed in 6 probands (32%), and cataracts were noted in association with the keratoconus in 5 of these 6 patients. Distinct hydrops with scarring and breaks in the Descemet membrane were noted in proband 17. The cataracts ranged from cortical changes to posterior subcapsular cataracts. Of interest, keratoconus and cataracts were only seen in patients who were homozygous for AIPL1 mutations. Keratoconus was not observed in patients with compound heterozygous mutations. The youngest patient with keratoconus and cataract was aged 10 years.
OPTIC DISC APPEARANCE
Varying degrees of optic nerve pallor were noted in all patients after the age of 6 years. The optic nerve head appeared normal in children younger than 6 years, except in an infant (Table 1) .
ERG FINDINGS
The ERG findings obtained in the 3 sets of clinically normal parents of probands 7, 10, and 26 who carry the AIPL1 mutation in a heterozygous state did not show any abnormalities. However, the ERG of 1 carrier parent of proband 2 with the W88X mutation showed significant rod abnormalities (Figure 8 ). She did not have any ocular complaints, and her clinical examination findings were normal. This 47-year-old mother had vision of 20/20 OU. Although her retinal examination results were unremarkable, full-field flash ERG showed rod b-wave amplitudes to be reduced to approximately one third of normal, with no change in implicit time. This is well below the lower limit of normal. The 30-Hz flicker and single flash cone 
COMPARING THE LCA PHENOTYPES
The LCA phenotypes with mutations in the other LCA genes (GUCY2D, RPE65, CRX, CRB1, and RPGRIP1) were compared with the LCA phenotypes of the current study and tabulated in Tables 2, 3 , 4, 5, and 6. The AIPL1-related LCA phenotype is severe in nature, with pronounced macular involvement in individuals older than 6 years with varying degrees of optic nerve pallor. Additional findings of keratoconus and cataract could be present.
Both GUCY2D-related and AIPL1-related LCA phenotypes have markedly decreased visual acuities, visual fields, and ERGs. 30, 31, 33 However, maculopathy, remarkable peripheral pigmentary changes, cataract, and significant optic disc pallor were not detected in patients with mutations in GUCY2D. 30, 31, 33 Keratoconus was reported by El-Shanti et al 36 in a Jordanian pedigree. Compared with the reported GUCY2D phenotype, 30, 31, 33 the AIPL1 phenotype appears to be similar in severity of visual loss. Phenotypical differences exist in the pattern of pigmentary changes, cataract, and keratoconus, which are more frequent in AIPL1-related LCA ( Table 2) .
The RPE65 phenotype reported in earlier studies [30] [31] [32] 37, 38 shows that the visual acuities, visual fields, and ERG measurements were better than in the AIPL1 phenotype. Patients with RPE65-related LCA may develop a mild maculopathy, and the documented peripheral retinal changes are characterized as grainy and/or salt and pepper-like. The maculopathy of patients with AIPL1-related LCA appears to be more pronounced in all probands older than 6 years, while the peripheral retinal changes range from mottling to bone spicule-like formation. Cataract and keratocunus were present in one third of the patients with AIPL1-related LCA. Lorenz et al 32 conclude that patients with LCA and RPE65 mutations are distinguishable on clinical grounds, based on their measurable visual acuities, their transient visual improvement in childhood followed by de- terioration in later life, measurable cone ERGs (which also diminish in later life), measurable visual fields, and significant night blindness. The data from our study suggest that patients with LCA and mutations in AIPL1 do not have a similar course (Table 3) . From the several reported cases of patients with LCA and CRX mutations, visual acuities of 20/300 to light perception, with 1 case of 20/80, were described. 15, 16, [19] [20] [21] [22] 31, 33, [39] [40] [41] [42] [43] Marked atrophy in the macula was recorded in 71% of CRX-related LCA, while in AIPL1-related LCA, maculopathy was pronounced in 80% of the patients after 6 years of age. Marked pigmentary retinopathy was noticed in 84% of patients with AIPL1-related LCA unlike in CRX-related LCA, where it was observed in 33% (Table 4 ).
Compared with that of patients with CRB1 mutations, the phenotype of our patients with AIPL1 mutations appears to be less variable and more severe. Small white dots and zonal retinal/choroidal hypoplasia were seen in the patients with CRB1-related LCA 23 but not in patients with AIPL1-related LCA ( Table 5 ). The presence of cataract, keratoconus, and optic disc pallor were not reported in the CRB1-related LCA phenotype. The constant features reported in the CRB1-related phenotype were moderate to high hyperopia, the relatively early appearance of white spots, and nummular pigment clumps in the retina. 23 The RPGRIP1-related LCA phenotype has been reported in 3 patients. 25 Visual acuity was light perception. Hyperopia and absence of intraretinal pigment mi- gration were noted in 2 patients. However, bone spiculelike pigmentary deposits in the midperipheral zone were noted in a third patient. No evidence of maculopathy as seen in the patients with AIPL1-related LCA was observed (Table 6 ).
COMMENT
The retinal phenotype of AIPL1-related LCA is that of a severe, congenital retinal dystrophy with a notable maculopathy. The retinal appearances in our patients ranged from near normal (in a 3-year-old and a 6-year-old) to severely atrophic (and in all patients older than 6 years) with marked maculopathy and pigmentary retinopathy. Varying degrees of intraretinal pigment migration culminating in bone spicule-like pigment and gross pigment clumps in the retinas were observed. Overall, a high prevalence of macular lesions was observed in our patients compared with patients with LCA caused by mutations in the other 5 genes implicated in this disease. Atrophic macular lesions were particularly frequent and were observed in 16 (80%) of 20 patients; 11 harbored a premature stopcodon mutation, either in a homozygous or a heterozygous state. Macular involvement as seen on ophthalmoscopy likely begins with an indistinct dull or irregular foveal reflex and progresses to a diffuse ill-defined area of retinal pigment stippling and atrophy, leading to a marked atrophic maculopathy. Owing to the differences in age at the time of first examination, it was not possible to determine the accurate age of onset of the maculopathy. Jacobson et al, 21 Lotery et al, 33 Nakamura et al, 42 Rivolta et al, 41 Silva et al, 22 Sohocki et al, 15 Swaroop et al, 43 Zhang Abbreviation: RPE, retinal pigment epithelium. *Nummular pigmentation in the retina and retinal zonal atrophy with hypoplasia of the choriocapillaris and RPE were present in some patients in the Lotery et al study but absent in the current study. Small retinal dots were present in many of the patients in the Lotery et al study but absent in the current study. The heterozygous carrier parent of the W88X mutation was found to have a significant and reproducible rod ERG abnormality with essentially normal cone ERG results. These ERG findings are significantly different from the heterozygous carriers of GUCY2D mutations, who have significant cone ERG abnormalities but relatively normal rod ERG findings. 34 The rod ERG abnormalities in the AIPL1 carrier correlate with recent reports showing AIPL1 expression exclusively in rod photoreceptors in the differentiated retina. 44 However, more ERGs in carriers of AIPL1 mutations need to be studied to better understand the role of AIPL1 in relation to rod function.
The presence of keratoconus in patients with LCA has been well documented. [45] [46] [47] [48] The high incidence of keratoconus in patients with a homozygous sequence change of AIPL1 in our cohort may well be significant. Keratoconus was observed in 6 probands, all with homozygous mutations. There is no definitive consensus about the origin of keratoconus in patients with LCA. The incidence of keratoconus has been reported to be as high as 54.5 cases per 100.0 in the general population, and it has been noted in 29% of children with LCA and 2% of all children with blindness. 10, 49 Keratoconus in patients with LCA occurred in 2% of 0-to 14-year-olds and in 30% of 15-to 45-year-olds, further illustrating the later onset of the pathologic corneal features in comparison with the retinal dysplasia. 50 The absence of keratoconus prior to 9 years of age also has been well documented 46 and is the case in our cohort too.
Cataract has been associated with many different types of retinal dystrophy. Its association with retinitis pigmentosa has been well documented. 51, 52 Cataract has been noted at or beyond the second decade of life in patients with LCA. 46 In this study, cataracts were observed in 5 probands (27%). Progressive retinal degenerative changes in association with keratoconus and cataract have been reported during the course of the disorder. 46, 47 The incidence of both keratoconus and cataract increased with increasing age in our cohort.
The LCA phenotypes are highly variable 15, 23, 31, 32 and change with age, 46 and the phenotypes associated with the currently known LCA genes overlap. [31] [32] [33] Comparisons between the reported LCA phenotypes of different studies 23, 25, [30] [31] [32] [33] are hampered by a lack of uniform assessment strategies, age matching, and uniform follow-up. Despite these obvious difficulties, it is important to study these LCA phenotypes in an effort to understand the evolution of disease based on genotype.
In summary, patients with AIPL1-related LCA appear to have a particularly severe phenotype, characterized by marked visual impairment, nondetectable fields and ERGs, optic disc pallor, maculopathy, peripheral retinal bone spicule-like pigmentation, and a significant prevalence of keratoconus and cataract.
Mutations in AIPL1 disrupt the normal function of photoreceptors. AIPL1 is not only expressed in mature rod photoreceptors 44 but also during development in both rods and cones. 29 The dysfunctional role of AIPL1 in photoreceptor cell cycle progression leads to photoreceptor cell death during development by disrupting the normal regulation of the cell cycle. 29 More detailed understanding of the pathogenesis of each molecular subtype of LCA will provide further insight into treatment.
